At the conclusion of this educational activity, the participant should be able to:
1) Describe mode of action of motixafortide and similarity/difference to plerixafor (longer duration of action for motixafortide)
2) Describe GENESIS trial (patient population, intervention timing, outcome comparison [achievement of >=6e6 CD34 cells/kg])
3) Summarize effectiveness and adverse events. Motixafortide significantly improved the success of collections.
 

Session date: 
06/11/2025 - 3:00pm to 4:00pm EDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Completion
  • 1.00 Nursing CEU
Please login or register to take this course.